Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for depression, anxiety and craving associated with alcoholism
2005-006195-35Phase 4Active
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of escitalopram in alcohol use disorder (AUD), major depressive disorder (MDD) and anxiety disorder, sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Depression associated with alcoholism. Started Oct 2007; status: active.
02
Drugs
escitalopram
03
Conditions
alcohol use disorder (AUD)major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on 2005-006195-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006195-35.